Contact Lenses News

SEATTLE — In this Healio Video Perspective from the ARVO meeting, William Reindel, OD, discusses the impact of pupil size on vision and comfort performance of a new multifocal daily disposable contact lens.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Marjorie Rah, OD, PhD, FAAO, discusses a poster that investigated Biotrue Hydration Plus Multipurpose solution from Bausch + Lomb.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Cynthia Matossian, MD, FACS, discusses how a soft contact lens may deliver medication to the front of the eye as an alternative to eye drops.

Johnson & Johnson Vision Care announced that the FDA has approved its Acuvue Theravision with Ketotifen daily disposable contact lenses.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Michelle K. Rhee, MD, discusses the importance of contact lenses in serving younger patients.

The Japanese Ministry of Health, Labour and Welfare approved Johnson & Johnson Vision’s Acuvue Theravision with Ketotifen, a drug-releasing combination contact lens designed for both vision correction and allergic eye itch relief.

AZR-MD-001, under investigation for the treatment of contact lens discomfort, has reached the primary endpoints in the phase 2 ECLIPTIC study, according to a press release from Azura Ophthalmics.

As questions and mixed information about how to remain safe during the COVID-19 pandemic continue to circle online, the CDC and data from a new peer-reviewed paper by five prominent ocular scientists confirm that healthy individuals can continue to wear contact lenses.

Healio.com/OSN is the online home of Ocular Surgery News. In addition to housing the online version of OSN, Healio/OSN creates daily news, meeting news coverage, executive summaries of journal articles, perspectives, videos, blogs and podcasts. With the increasing importance of Healio as the online presence of Ocular Surgery News and the continuous growth that is taking place online, we decided it was a good time to boost the Healio/OSN editorial board presence in the ophthalmic community.